Wrap Text
Form 8-K current report
ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")
FORM 8-K CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, ASPI stockholders are advised
that a Form 8-K has been filed with the U.S. Securities and Exchange Commission.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers
On January 7, 2026, the Company announced that in connection with the closing of the Company's
previously announced acquisition of Renergen Limited ("Renergen"), on January 6, 2026 (the "Closing
Date"), Stefano Marani, the Chief Executive Officer of Renergen, was appointed as the President,
Electronics and Space, of the Company, and Nick Mitchell, the Chief Operating Officer of Renergen, was
appointed Co-Chief Operating Officer of the Company.
Mr. Marani, age 48, has served as the Chief Executive Officer of Renergen and a member of the Board of
Directors of Renergen since November 2014. As co-founder of Renergen, Mr. Marani is responsible for
managing Renergen's overall operations, including the execution of the Virginia Gas Project. Mr. Marani
was part of the team which acquired the Gas Fields from Molopo Energy Limited in April 2013 and was
instrumental in taking the Gas Fields from a stranded gas asset into production with funding from the United
States government. Mr. Marani has significant experience in the areas of structured finance and advisory,
having previously worked at Deutsche Bank and Morgan Stanley. Mr. Marani holds a BSc in Actual Science
and a BSc (Hons) in Advance Mathematics of Finance from the University of Witwatersrand.
Mr. Mitchell, age 46, has served as Chief Operating Officer and a member of the Board of Directors of
Renergen since November 2015. In this capacity, he drives Renergen's strategic direction and oversees all
operational activities, including the flagship Virginia Gas Project. Since March 2017, Mr. Mitchell has
chaired the Oil and Natural Gas Producers Association of South Africa (ONPASA), and he has been a
Trustee of the South African Oil and Gas industries Upstream Training Trust (UTT) since December 2020,
thereby contributing to industry leadership, policy development and youth skills and knowledge
development. His entrepreneurial vision was instrumental in transforming Tetra4 from a stranded gas asset
into a world-class helium and natural gas reserve following its acquisition in 2013. Mr. Mitchell brings
extensive expertise in operations management, commercial development, and strategic risk management.
Mr. Mitchell qualified as a Microsoft Certified Systems Engineer and was also A+ Certified.
The Company expects to enter into an employment agreement with Mr. Marani providing for a base salary
of $550,000 per annum (subject to annual adjustments by the board of directors) and a target annual
discretionary bonus equal to 50% of his annual base salary. The Company expects to enter into an
employment agreement with Mr. Mitchell providing for a base salary of $400,000 per annum (subject to
annual adjustments by the board of directors) and a target annual discretionary bonus equal to 50% of his
annual base salary. Annual bonuses will be paid in a mixture of cash and common stock, as determined by
the compensation committee. Once the terms of such employment agreements are finalized, the Company
will file an amendment to this Current Report on Form 8-K to report any additional information required by
Item 5.02 of Form 8-K within four business days after such information is determined or becomes available.
As previously disclosed, in connection with the closing of the acquisition of Renergen, the Company's
Compensation Committee approved the grant to each of Messrs. Marani and Mitchell 700,000 shares of
the Company's common stock. Subject to each recipient being continuously employed by the Company
through each applicable vesting date, the shares will vest in eight equal instalments over four years, with
87,500 shares vesting on each of the six-month anniversaries of each recipient's employment start date.
The restricted stock awards are made pursuant to the Company's 2024 Inducement Equity Incentive Plan
and the Company's 2025 Inducement Equity Incentive Plan as an inducement material to each recipient
entering into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4), and will
be subject to the terms and conditions of the applicable award agreements to be entered into between the
Company and each recipient thereof. Messrs. Marani and Mitchell will also be eligible to receive annual
equity-based awards pursuant to the Company's 2022 Equity Incentive Plan.
Messrs. Marani and Mitchell will also enter into the Company's standard form of indemnification agreement,
a copy of which has been incorporated by reference as Exhibit 10.4 to the Company's Annual Report on
Form 10-K filed with the Securities and Exchange Commission on March 31, 2025.
Except as previously disclosed by the Company in its Form 8-K filed on May 20, 2025, there are no
arrangements or understandings between Mr. Marani or Mr. Mitchell and any other person pursuant to
which either Mr. Marani or Mr. Mitchell was selected as an officer of the Company. There are no family
relationships between Mr. Marani or Mr. Mitchell and any of the executive officers or directors of the
Company. There is no information that is required to be disclosed with respect to Mr. Marani or Mr. Mitchell
pursuant to Item 404(a) of Regulation S-K, except for the transactions between the Company and Renergen
that have been previously disclosed by the Company, including the $30 million bridge loan agreement,
dated May 19, 2025, by and among the Company, ASP Isotopes South Africa Proprietary Limited, as
lender, and Renergen, as borrower, as disclosed by the Company in its Form 8-K filed on May 20, 2025
and subsequent SEC filings. As a result of such financial relationship between the Company and Renergen,
Mr. Marani and Mr. Mitchell may be deemed to have a direct or indirect material interest with respect to the
Company's transactions with Renergen as contemplated by Item 404(a) of Regulation S-K.
A copy of the Form 8-K can also be found at: Inline Viewer: ASP Isotopes Inc. 8-K 2026-01-06
The Company has a primary listing on the Nasdaq and a secondary listing on the Main Board of the JSE.
13 January 2026
Sponsor
Valeo Capital Proprietary Limited
Date: 13-01-2026 08:02:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
